Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-16 | New | $1,791,165 | $1,791,165 | Equity Only | 06b | SEC link |
| 2023-08-25 | New | $250,000 | $250,000 | Other | 06b | SEC link |
| 2023-06-12 | Amended | $3,065,000 | $150,000 | Other | 06b | SEC link |
| 2023-03-01 | Amended | $2,915,000 | $1,015,000 | Other | 06b | SEC link |
| 2022-06-03 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2022-06-03 | New | $1,900,000 | $1,900,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Reza Dana | Director |
| David Neafus | Executive |
| Jason Werner | Director, Executive |
| Samuel Wu | Director |
| Wenkai Xiang | Director |
| Jiagang Zhao | Director |